Search

61 Result(s)
Sort by

About Chronic Kidney Disease

About Chronic Kidney Disease

CKD is very common and often goes undetected due to its silent nature. Risk factors include high blood pressure and type 2 diabetes.
Chronic Kidney Disease

Chronic Kidney Disease

Chronic Kidney Disease, or CKD, is caused by progressive damage to the kidneys, affecting 10% of the population.
Lung Diseases

Lung Diseases

Find information on a variance of respiratory diseases such as asthma, COPD, idiopathic pulmonary fibrosis (IPF), Scleroderma and lung cancer.
Fighting Foot and Mouth Disease

Fighting Foot and Mouth Disease

Foot and mouth disease (FMD) is a highly contagious viral disease that affects cloven-hoofed animals such as cattle, pigs, sheep, and goats. Boehringer Ingelheim France is cooperating with its Kazakh partner QazBioPharm to manufacture vaccines.
Skin Diseases

Skin Diseases

Skin Diseases | We discover and develop breakthrough therapies that can be used to prevent, treat and repair many inflammatory and fibrotic diseases.
Retinal Diseases

Retinal Diseases

At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye.
Scleroderma

Scleroderma

Systemic sclerosis is a complex rare disease with a variable course. It presents with a range of symptoms involving several different organs
MASH

MASH

Learn more about the metabolic disease known as non-alcoholic steatohepatitis (MASH) here
Lung Cancer

Lung Cancer

Building on our experience in lung disease, our goal is to take lung cancer on, transform the treatment landscape and ultimately, redefine all lung cancers as curable.
Testing New Treatments for NF1

Testing New Treatments for NF1

The Medical University of Vienna and Boehringer Ingelheim have taken an innovative approach to the development of ways of treating NF1-associated tumors.
Biotherapeutics Discovery

Biotherapeutics Discovery

Our committed team of scientists are using all their experience and knowledge to forge new research paths, engineer new molecules and do whatever it takes to make sure that no patient is left behind in our search for the next breakthrough.
Our innovation strategy

Our innovation strategy

Our Innovation Strategy at Boehringer Ingelheim in Research and Development